The long non-coding RNA HOTAIR is upregulated in endometrial carcinoma and correlates with poor prognosis

International Journal of Molecular Medicine

Volumn 33, Issue 2, 2014, Pages 325-332

  He, Xiaoying ^a   Bao, Wei ^a   Li, Xiaocui ^a   Chen, Zheng ^b   Che, Qi ^b   Wang, Huihui ^b   Wan, Xiao Ping ^b  

^a SHANGHAI CHILDREN S HOSPITAL   (China)

^b SHANGHAI FIRST PEOPLE S HOSPITAL   (China)

Author keywords

Endometrial carcinoma; Homeobox (HOX) transcript antisense intergenic RNA; Long non coding RNA; Prognosis

Indexed keywords

HOMEOBOX TRANSCRIPT ANTISENSE INTERGENIC RNA; LONG UNTRANSLATED RNA; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CANCER PROGNOSIS; CANCER SURVIVAL; CONTROLLED STUDY; CYTOPLASM; DISEASE ASSOCIATION; ENDOMETRIOID CARCINOMA; ENDOMETRIUM CARCINOMA; ENDOMETRIUM HYPERPLASIA; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MIDDLE AGED; OVERALL SURVIVAL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA SEQUENCE; UPREGULATION;

DISEASE PROGRESSION; ENDOMETRIAL NEOPLASMS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHATIC METASTASIS; MIDDLE AGED; PROGNOSIS; RNA, LONG NONCODING; UP-REGULATION;

EID: 84893749412     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.2013.1570     Document Type: Article

References (36)

1. Siegel R, Naishadham D and Jemal A: Cancer statistics, 2013. CA Cancer J Clin 63: 11-30, 2013.
2. Schouten LJ, Goldbohm RA and van den Brandt PA: Anthropometry, physical activity, and endometrial cancer risk: Results from the Netherlands Cohort Study. J Natl Cancer Inst 96: 1635-1638, 2004.
3. Bokhman JV: Two pathogenetic types of endometrial carcinoma. Gynecol Oncol 15: 10-17, 1983.
4. Boll D, Verhoeven RH, van der Aa MA, et al: Incidence and survival trends of uncommon corpus uteri malignancies in the Netherlands, 1989-2008. Int J Gynecol Cancer 22: 599-606, 2012.
5. Rose PG: Endometrial carcinoma. N Engl J Med 335: 640-649, 1996.
6. Lax SF: Molecular genetic pathways in various types of endometrial carcinoma: From a phenotypical to a molecular-based classification. Virchows Arch 444: 213-223, 2004.
7. Saal LH, Johansson P, Holm K, et al: Poor prognosis in carcinoma is associated with a gene expression signature of aberrant PTEN tumor suppressor pathway activity. Proc Natl Acad Sci USA 104: 7564-7569, 2007.
8. Park JY, Kim KR and Nam JH: Immunohistochemical analysis for therapeutic targets and prognostic markers in low-grade endometrial stromal sarcoma. Int J Gynecol Cancer 23: 81-89, 2013.
9. Salvesen HB, Carter SL, Mannelqvist M, et al: Integrated genomic profiling of endometrial carcinoma associates aggres-sive tumors with indicators of PI3 kinase activation. Proc Natl Acad Sci USA 106: 4834-4839, 2009.
10. Knauss JL and Sun T: Regulatory mechanisms of long noncoding RNAs in vertebrate central nervous system development and function. Neuroscience 235: 200-214, 2013.
11. Mercer TR, Dinger ME and Mattick JS: Long non-coding RNAs: Insights into functions. Nat Rev Genet 10: 155-159, 2009.
12. Gibb EA, Brown CJ and Lam WL: The functional role of long non-coding RNA in human carcinomas. Mol Cancer 10: 38, 2011.
13. Huarte M and Rinn JL: Large non-coding RNAs: Missing links in cancer? Hum Mol Genet 19: R152-R161, 2010.
14. Mourtada-Maarabouni M, Pickard MR, Hedge VL, Farzaneh F and Williams GT: GAS5, a non-protein-coding RNA, controls apoptosis and is downregulated in breast cancer. Oncogene 28: 195-208, 2009.
15. Matouk IJ, DeGroot N, Mezan S, et al: The H19 non-coding RNA is essential for human tumor growth. PLoS One 2: E845, 2007.
16. Ji P, Diederichs S, Wang W, et al: MALAT-1, a novel noncoding RNA, and thymosin beta4 predict metastasis and survival in early-stage non-small cell lung cancer. Oncogene 22: 8031-8041, 2003.
17. Gupta RA, Shah N, Wang KC, et al: Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metas-tasis. Nature 464: 1071-1076, 2010.
18. Cooper C, Guo J, Yan Y, et al: Increasing the relative expression of endogenous non-coding Steroid Receptor RNA Activator (SRA) in human breast cancer cells using modified oligonucleotides. Nucleic Acids Res 37: 4518-4531, 2009.
19. Ge X, Chen Y, Liao X, et al: Overexpression of long noncoding RNA PCAT-1 is a novel biomarker of poor prognosis in patients with colorectal cancer. Med Oncol 30: 588, 2013.
20. Schalken JA, Hessels D and Verhaegh G: New targets for therapy in prostate cancer: Differential display code 3 (DD3(PCA3)), a highly prostate cancer-specific gene. Urology 62: 34-43, 2003.
21. Chisholm KM, Wan Y, Li R, Montgomery KD, Chang HY and West RB: Detection of long non-coding RNA in archival tissue: Correlation with polycomb protein expression in primary and metastatic breast carcinoma. PLoS One 7: E47998, 2012.
22. Yang Z, Zhou L, Wu LM, et al: Overexpression of long non-coding RNA HOTAIR predicts tumor recurrence in hepato-cellular carcinoma patients following liver transplantation. Ann Surg Oncol 18: 1243-1250, 2011.
23. Kogo R, Shimamura T, Mimori K, et al: Long noncoding RNA HOTAIR regulates polycomb-dependent chromatin modifica-tion and is associated with poor prognosis in colorectal cancers. Cancer Res 71: 6320-6326, 2011.
24. Zhuang Y, Wang X, Nguyen HT, et al: Induction of long intergenic non-coding RNA HOTAIR in lung cancer cells by type I collagen. J Hematol Oncol 6: 35, 2013.
25. Tsai MC, Manor O, Wan Y, et al: Long noncoding RNA as modular scaffold of histone modification complexes. Science 329: 689-693, 2010.
26. Nie Y, Liu X, Qu S, Song E, Zou H and Gong C: Long non-coding RNA HOTAIR is an independent prognostic marker for nasopharyngeal carcinoma progression and survival. Cancer Sci 104: 458-464, 2013.
27. Coons AH, Creech HJ and Jones RN: Immunological properties of an antibody containing a fluorescent group. Proc Soc Exp Biol Med 47: 200-202, 1941.
28. Cancer Genome Atlas Research Network, Kandoth C, Schultz N, et al: Integrated genomic characterization of endometrial carcinoma. Nature 497: 67-73, 2013.
29. Amant F, Moerman P, Neven P, Timmerman D, Van Limbergen E and Vergote I: Endometrial cancer. Lancet 366: 491-505, 2005.
30. Zhang XQ, Sun S, Lam KF, et al: A long non-coding RNA signature in glioblastoma multiforme predicts survival. Neurobiol Dis 58: 123-131, 2013.
31. Kim K, Jutooru I, Chadalapaka G, et al: HOTAIR is a negative prognostic factor and exhibits pro-oncogenic activity in pancreatic cancer. Oncogene 32: 1616-1625, 2013.
32. Lv XB, Lian GY, Wang HR, Song E, Yao H and Wang MH: Long noncoding RNA HOTAIR is a prognostic marker for esophageal squamous cell carcinoma progression and survival. PLoS One 8: E63516, 2013.
33. Niinuma T, Suzuki H, Nojima M, et al: Upregulation of miR-196a and HOTAIR drive malignant character in gastrointestinal stromal tumors. Cancer Res 72: 1126-1136, 2012.
34. Bhan A, Hussain I, Ansari KI, Kasiri S, Bashyal A and Mandal SS: Antisense transcript long noncoding RNA (lncRNA) HOTAIR is transcriptionally induced by estradiol. J Mol Biol 425: 3707-3722, 2013.
35. Lu L, Zhu G, Zhang C, et al: Association of large noncoding RNA HOTAIR expression and its downstream intergenic CpG island methylation with survival in breast cancer. Breast Cancer Res Treat 136: 875-883, 2012.
36. Gutschner T and Diederichs S: The hallmarks of cancer: A long non-coding RNA point of view. RNA Biol 9: 703-719, 2012.